RALEIGH, N.C., Nov. 10 /PRNewswire/ -- HyperBranch Medical Technology, Inc. announced today the company was selected as the Outstanding Early Stage Presentation Tuesday during the Sixth Annual Southeastern Bio Investor Forum (SEBIO.) HyperBranch was attending its first investor conference.
HyperBranch, one of sixteen early-stage companies competitively selected to present at SEBIO, became one of four semi-finalists and then overall winner of Outstanding Early Stage Presentation Tuesday afternoon at the Doral Golf Resort & Spa in Miami. SEBIO awarded HyperBranch a plaque along with the title.
“It is a tremendous honor to be given this award, especially since there were fifteen other companies who also had amazing technology,” said Anthony Sherbondy, co-founder, president and chief executive officer of HyperBranch. “We hope this award helps continue the momentum toward achieving our funding milestones.”
About HyperBranch
Founded in early 2003 and based in Raleigh, North Carolina, HyperBranch Medical Technology, Inc. is a privately held biomaterial medical device company, formed to develop products for ocular surgery, products that help to restore vision or prevent serious vision loss, created using principles from polymer chemistry and biomedical engineering. Please visit http://www.hyperbranch.com/ .
HyperBranch Medical Technology, Inc.
CONTACT: Anthony Sherbondy, President and CEO of HyperBranch MedicalTechnology, Inc., +1-919-845-8223, or anthonys@hyperbranch.com ; or SamanthaRode of Maverick Marketing, +1-919-459-2775, or srode@maverickmarketing.com ,for HyperBranch
Web site: http://www.hyperbranch.com/
